Evaluation of Efficacy and Safety of Topical 1% Medroxyprogesterone in the Corneal Epithelium Healing After PRK

NCT05973253 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
74
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Isfahan University of Medical Sciences

Collaborators